Markets:

Overview

News

Currencies

International

Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

101.91 -1.44 (-1.39%)

Streaming Delayed Price Updated: 11:22 AM EDT, Jun 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corporation Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Glaukos Announces Participation in the Wells Fargo Healthcare Conference

August 24, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Stock Scores Rising Price Performance With Jump To 91 RS Rating ↗

August 16, 2022

On Tuesday, Glaukos stock hit an key technical milestone, with its Relative Strength Rating climbing to 91, up from 87 the day before.

Via Investor's Business Daily

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 03, 2022

Via Benzinga

Glaukos: Q2 Earnings Insights ↗

August 03, 2022

Glaukos (NYSE:GKOS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Glaukos missed estimated earnings by...

Via Benzinga

Glaukos Receives FDA 510(k) Clearance For iStent infinite ↗

August 03, 2022

The U.S.

Via Benzinga

Glaukos: Q4 Earnings Insights ↗

February 22, 2022

Glaukos (NYSE:GKOS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Glaukos...

Via Benzinga

Earnings Scheduled For February 22, 2022 ↗

February 22, 2022

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...

Via Benzinga

Analyst Ratings For Glaukos ↗

January 19, 2022

Glaukos (NYSE:GKOS) has observed the following analyst ratings within the las...

Via Benzinga

Glaukos Announces FDA 510(k) Clearance of iStent infinite®

August 03, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Corporation Announces Second Quarter 2022 Financial Results

August 03, 2022

From Glaukos Corporation

Via Business Wire

Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3

July 13, 2022

From Glaukos Corporation

Via Business Wire

The 6 Most Aggressive Growth Stocks to Buy in July ↗

July 12, 2022

These are the 6 most aggressive growth stocks to buy in July. They reflect huge potential growth in their sales and/or their earnings.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022 ↗

July 12, 2022

Upgrades

Via Benzinga

Glaukos Announces Participation in the William Blair Growth Stock Conference

June 02, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium

May 20, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Corporation Announces First Quarter 2022 Financial Results

May 04, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting

April 21, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Announces the Release of its 2021 Sustainability Report

April 20, 2022

From Glaukos Corporation

Via Business Wire

Glaukos to Release First Quarter 2022 Financial Results after Market Close on May 4

April 13, 2022

From Glaukos Corporation

Via Business Wire

Sight Sciences' Q4 Earnings, FY22 Guidance Beat Street View ↗

March 25, 2022

Sight Sciences Inc (NASDAQ: SGHT) has treated the first patient in the TRIDENT trial evaluating OMNI Surgical System compared to Glaukos Corp's (NYSE...

Via Benzinga

Glaukos Announces Commencement of Phase 2 Corneal Health Clinical Program for Third-Generation iLink™ Therapy

March 14, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Corporation Announces Fourth Quarter and Full Year 2021 Financial Results

February 22, 2022

From Glaukos Corporation

Via Business Wire

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

Glaukos Announces Executive Leadership Changes

February 07, 2022

From Glaukos Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022 ↗

February 03, 2022

Upgrades BTIG upgraded the previous rating for Insulet Corp (NASDAQ:PODD) from Neutral to Buy. For the third quarter, Insulet had an EPS of $0.18, compared to year-ago...

Via Benzinga

Glaukos Corporation to Release Fourth Quarter and Full Year 2021 Financial Results after Market Close on February 22

February 01, 2022

From Glaukos Corporation

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022 ↗

January 19, 2022

Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...

Via Benzinga

The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award ↗

January 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Biogen Shares Slip On Restricted Coverage For Its Alzheimer's Drug Biogen...

Via Benzinga

Glaukos' iDose TR Shows Sustained Reduction In Ocular Pressure, Favorable Safety Profile ↗

January 12, 2022

Ophthalmic medical company Glaukos Corporation (NYSE: GKOS) announced data from the Phase 2b trial of iDose TR, a sustained-release travoprost implant. The...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.